In 2024 alone, pharmaceutical companies spent $7.7 billion on trials for drug candidates that were ultimately terminated
"Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population"
THC metabolites
Every two weeks is the standard cadence for at-home microinfusion
[11] [6] Rare but serious reactions: Although uncommon, anaphylaxis (severe allergic reaction) can occur
ARA 290 has been evaluated extensively in a wide spectrum of preclinical models, including diet-induced insulin resistance (10), diabetic retinopathy (11), diabetic autonomic neuropathy (12), myocardial infarction (13), chronic heart failure (14), burns (15), traumatic brain injury (16,17) and shock-induced multi-organ failure (18), among others